Concepedia

Barbara Czakó

BC

22

Publications

1.7K

Citations

16

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Harvard University

Beth Israel Deaconess Medical Center

University of Pennsylvania

Comenius University Bratislava

Barbara Czakó is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and organic chemistry.

ORCID

Top concepts

Publications per year

2004–2023

22

Publications

22

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

, , +4

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Yuting Sun, Brooke A. Meyers, Barbara Czakó et al. · Cancer Research · 2020 · 101 citations · Full text

SF2312 is a natural phosphonate inhibitor of enolase

Paul G. Leonard, Nikunj Satani, David S. Maxwell et al. · Nature Chemical Biology · 2016 · 97 citations · Full text

, , +5

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 95 citations · Full text

, , +5

Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

Michael Soth, Kang Le, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2020 · 88 citations · Full text

Rows per page

1–5 of 22